News and Press

Filter By:

Avicanna Inc. Proudly Hosts the “International Symposium on Cannabinoids & Medical Applications”


TORONTO, Feb. 2, 2018 /PRNewswire/ – Avicanna Inc. (“Avicanna“) is pleased to announce that its Colombian subsidiary Sativa Nativa S.A.S. (“Sativa Nativa“) has been issued a psychoactive cannabis Cultivation license and a

Avicanna Inc. Announces its Subsidiary Has Obtained Medical Cannabis Licenses in Colombia


TORONTO, Feb. 2, 2018 /PRNewswire/ – Avicanna Inc. (“Avicanna“) is pleased to announce that its Colombian subsidiary Sativa Nativa S.A.S. (“Sativa Nativa“) has been issued a psychoactive cannabis Cultivation license and a

Avicanna Completes 2nd Equity Financing & Welcomes New Strategic Shareholder


TORONTO, Canada/January 29, 2018: Avicanna Inc., (“Avicanna”) is pleased to announce the completion of its non-brokered private placement offering (the “Offering”) for units in Avicanna (each a “Unit”). Each Unit

Marijuana Meds and Myths


At the end of June, more than 200,000 Canadians were registered to buy medical marijuana from more than 60 licensed Canadian producers. People use the drug to treat everything from

MEET THE FIRST CANNABUSINESS TO BE ACCEPTED INTO JOHNSON & JOHNSON’S INNOVATION LAB


This article was originally published on Benzinga, and adapted exclusively for HIGH TIMES. As a cannabis company, Avicanna did not know what the outcome would be when applying to be part of JLABS @ Toronto. Yet, they were decided

1 2